(Accessed: March 24, 2023)
Shaking can cause foaming, which indicates that the peptide chains are breaking and the compound is losing its efficacy for your metabolic assays
In clinical trials of Wegovy as an adjunct to lifestyle modification, participants lost an average of 15 percent of their body weight with more than half the people treated with Wegovy losing more than 15 percent of their starting weight - up to five times the average weight loss seen with traditional diet and exercise plans
Patients with active cancer, a history of pituitary tumors, or severe metabolic disease should discuss growth-hormone peptide therapy carefully with both their primary clinician and specialist before starting
Conversely, administration of HU210 (a CB1 agonist) significantly stimulated hypothalamic AMPK activity and inhibited visceral fat and liver AMPK activity in wild-type mice, but these effects were lost in GHSR KO animals (Lim et al., 2013)
Some people find that eating a small, bland meal shortly before or after their tirzepatide dose helps reduce nausea
